Integrum expands in Australia with a new center in Sydney
Australia is one of the leading countries in the world when it comes to Osseointegration for Amputation Rehabilitation. The OPRA™ Implant System allows for direct connection of an artificial limb to the skeleton, making the prosthesis a true extension of one’s body.
The first osseointegration case with the OPRA™ Implant System has just been performed by Dr Sean Nicklin and Dr Phil Huang at Prince of Wales Private hospital in Sydney. Dr Nicklin is the head of the plastic surgery Unit at Prince of Wales Public Hospital and Dr Huang is an orthopaedic lower limb surgeon with a biomedical engineering background who works at the Mater Hospital in North Sydney.
The Prince of Wales Private Hospital is one of the leading private hospitals in Sydney which specializes in various disciplines including neurosurgery and orthopaedics. It has a long and reputed history of providing quality health care and surgical excellence.
“The program in Sydney would not be possible if not for the tremendous support from Integrum AB as well as Mr Steven Gray and Dr Frank Bruscino-Raiola at the Alfred Hospital in Melbourne and Surgien Pty. Ltd. It is the culmination of hard work from many individuals over the last 2 and a half years”, says Dr Huang.
Besides Dr Sean Nicklin and Dr Phil Huang, the program in Sydney will also be headed by Dr Greg Bowring; a rehab specialist who heads one of the largest amputee services in Sydney.
“We are inspired to expand the availability of our products to address the needs of people with amputations and enable them with the technology to thrive in their endeavours”, says Maria Lopez, CEO of Integrum AB.
The OPRA™ Implant System was introduced in Australia by Dr Brånemark in 1995 in collaboration with the Alfred Hospital, which is the leading trauma hospital in Melbourne. The Plastic, Hand & Faciomaxillary Surgery Unit, Melbourne, Victoria - which hosts the A.S.A.P Advanced Surgical Amputation Programme, is headed by Mr. Steven Gray and Dr. Frank Bruscino-Raiola – Senior Plastic Surgeon & Director of Surgical Unit.
The information in this press release is information that Integrum AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the contact person set out below, at 14:00 CET on April 7st, 2020.Integrum AB is listed on Nasdaq First North in Stockholm. Erik Penser is the Company´s Certified Adviser.
For further information contact
María López, CEO. Mobile: +46 708 46 10 69, Email: maria.lopez@integrum.se
Certified Adviser
Erik Penser Bank AB, Certified Adviser can be reached at +46 8 463 8000 or certifiedadviser@penser.se
About Integrum
Integrum provides innovative solutions for bone-anchored prostheses. Integrum’s OPRATM implant system improves quality of life for amputees through higher prosthetic functionality, improved comfort and improved mobility. With 20 years’ experience from more than 500 surgeries in 14 countries, Integrum is a global leader in bone anchored protheses. The company’s share (INTEG B) is listed for trading on Nasdaq First North in Stockholm with Erik Penser Bank as Certified Advisor. Learn more at http://integrum.se/